Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 65Carcinoma, Non-Small-Cell Lung 46Neoplasms 9Breast Neoplasms 9Melanoma 7Head and Neck Neoplasms 7Ovarian Neoplasms 6Colorectal Neoplasms 5Small Cell Lung Carcinoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Neoplasm Metastasis 3Mesothelioma 3Kidney Neoplasms 3Esophageal Neoplasms 3Stomach Neoplasms 2Sarcoma 2Plaque, Atherosclerotic 2Liver Neoplasms 2Endometrial Neoplasms 2Disease 2Colonic Neoplasms 2Bronchitis, Chronic 2Adenocarcinoma 2Vulvar Neoplasms 1Uterine Neoplasms 1Urologic Neoplasms 1Thyroid Neoplasms 1

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Respiratory Distress Syndrome × Blood Specimen Collection × Thoracic × Clear all
NCT06122077 2025-08-05

PROACT-LUNG

Freenome Holdings Inc.

Recruiting
20,000 enrolled
Thoracic

Emphysema, Lung Neoplasms, Respiratory Distress Syndrome, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡